Regen Biopharma (RGBP) Financial Statements

Regen Biopharma's market cap is currently $972.49K. The company's EPS TTM is $-0.088; its P/E ratio is -0.05; Regen Biopharma is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.